Motivation: RNA-seq has become the technology of choice for interrogating the transcriptome. However, most methods for RNA-seq differential expression (DE) analysis do not utilize prior knowledge of biological networks to detect DE genes. With the increased availability and quality of biological network databases, methods that can utilize this prior knowledge are needed and will offer biologists with a viable, more powerful alternative when analyzing RNA-seq data. Results: We propose a three-state Markov Random Field (MRF) method that utilizes known biological pathways and interaction to improve sensitivity and specificity and therefore reducing false discovery rates (FDRs) when detecting differentially expressed genes from RNA-seq data. The method requires normalized count data (e.g. in Fragments or Reads Per Kilobase of transcript per Million mapped reads (FPKM/RPKM) format) as its input and it is implemented in an R package pathDESeq available from Github. Simulation studies demonstrate that our method outperforms the two-state MRF model for various sample sizes. Furthermore, for a comparable FDR, it has better sensitivity than DESeq, EBSeq, edgeR and NOISeq. The proposed method also picks more top Gene Ontology terms and KEGG pathways terms when applied to real dataset from colorectal cancer and hepatocellular carcinoma studies, respectively. Overall, these findings clearly highlight the power of our method relative to the existing methods that do not utilize prior knowledge of biological network. Availability and Implementation: As an R package at https://github.com/MalathiSIDona/pathDESeq To install the package type: install_github(MalathiSIDona/pathDESeq,build_vignettes ¼ TRUE). After installation, type vignette(pathDESeq) to access the vignette.
Introduction
In the last few years, next-generation sequencing (NGS) has replaced microarrays as the preferred technology for interrogating gene expression at genome-wide level. The advantages of RNA-seq over microarray includes better concordance with the gold standard PCR-based quantification, larger dynamic range over which expression can be detected and more uniform coverage and the possibility of estimating isoform-specific transcripts (Wang et al., 2009) . As for microarray data, the main objective of RNAseq experiments is to find genes that are differentially expressed V C The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com (DE) under two or more different conditions. Statistical methods for finding DE genes using microarray data mostly assume that the data follow either a normal distribution (e.g. Smyth, 2004) or a Gamma distribution (e.g. Newton et al., 2001) . These distributions are appropriate for continuous, intensity-based data such as microarray data. However, RNA-seq experiments produce digital count as output. The spread in count data is often related to the magnitude of its mean, with larger mean associated with larger spread. This nature of count data has led to development of statistical methods that assume an underlying Poisson (Wang et al., 2012) or negative binomial (NB) distributions (e.g. Anders and Huber, 2010; Robinson et al., 2010; Yanming et al., 2011) , as the Poisson distribution naturally takes care of the mean-dispersion dependence and the NB distribution is an extension of the Poisson distribution and is useful when the data exhibit extra variations unaccounted by the Poisson assumption. An alternative approach to handle the mean-dispersion dependence is to use logtransformed count data and incorporate the unequal dispersion as weights in a regression model (Ritchie et al., 2015) .
Thus far, most methods for RNA-seq data do not utilize biological network information when searching for DE genes. There is evidence that utilizing network information will result in not only more interpretable sets of statistically significant genes but also in increased sensitivity and specificity of the methods (Saxena et al., 2006; Wang and Cairns, 2014) . For microarray data, there are several methods that utilize biological network information. Gene-set enrichment analysis (GSEA; Subramanian et al., 2005) and similar methods such as Parametric Analysis of Gene Set Enrichment (PAGE) (Kim and Volsky, 2005) and Generally Applicable Gene-set Enrichment (GAGE) (Luo et al., 2009 ) accumulate evidence at the pathway level when searching for enriched pathways. More recently, GSEA has been extended to cater for RNA-seq data (Wang and Cairns, 2014) . However, none of these methods use the network structure directly when searching for DE genes. Wei and Li (2007) developed a Markov random field (MRF) model that allows DE status of a gene to depend on the DE status of its neighbors in the network. The MRF approach produces a DE status at gene level rather than at the pathway-level as produced by GSEA. This can be beneficial if only a small fraction of genes in a pathway is disrupted as the power of the pathwaylevel test to detect disruption will be limited. However, Wei and Li's model assumes that gene expression data follows a Gamma distribution, which is not natural for count-based RNA-seq data. Second, and more importantly from a biological perspective, their model does not make a distinction between down-regulated and up-regulated genes and implicitly does not discourage genes to be down-regulated in a pathway where the vast majority of genes are up-regulated and vice versa. This is despite empirical evidence showing that genes on the same pathway have a strong tendency to show the consistent direction of changes (Grü tzmann et al., 2005; Hong et al., 2014; Wang et al., 2012) .
In this paper, we address these limitations by developing an extension to Wei and Li's model. The extensions take place in two forms: first, we assume a Poisson rather than a Gamma distribution for the RNA-seq data and second, we make an explicit distinction between up-regulated and down-regulated genes by introducing a 3-state MRF model that encourages genes within the same pathway to have the same DE status. Using simulated data, we showed that our proposed method has better sensitivity relative to Wei and Li's method and the DESeq (Anders and Huber, 2010) , EBSeq (Leng et al., 2013) , edgeR (Robinson et al., 2010) and NOISeq (Tarazona et al., 2011) , which are popular R packages for analyzing RNA-seq data that do not utilize network information. Finally, applying our proposed method to two real datasets from colorectal cancer study (Kim et al., 2014) and hepatocellular carcinoma study (Liu et al., 2016) , we demonstrate that our methods identify more genes from biologically relevant pathways.
Statistical models and methods

Notations
The main objective when analyzing RNA-seq data is to detect transcripts or genes that are differentially expressed (DE) under two or more experimental conditions. In many scenarios, the direction of DE is also of interest where DE genes can be further classified based on their regulatory direction of expression levels as being either Up regulated (UR) or Down regulated (DR). DE genes usually constitute a small fraction of genes studied with the majority of genes are not affected by the experimental conditions. These non-affected genes are said to be equally expressed (EE) across the conditions.
For convenience, we label the three expression states numerically as 0, 1 and (À1) for EE, UR and DR, respectively. Hence, for an arbitrary individual, let x ¼ ðx 1 ; x 2 ; . . . ; x p Þ denote the states for p genes where
gene is equally expressed 1; gene is up regulated
Let y ¼ ðy 1 ; y 2 ; . . . ; y p Þ where y i is the RNA-seq expression for the ith gene that has been normalized against differences in sequencing depth and gene length. Restricting our attention to the ith gene only, suppose that we have m replicates under the first experimental condition (control), and n under the second condition (treatment). Then we can define y i ¼ ðy i;1 ; . . . ; y i;m ; y i;mþ1 ; . . . ; y i;mþn Þ to be the vector of m þ n observed replicates of RNA-seq expression. We let y i:m represent the summation of gene expression levels for the ith gene over first group as y i:m and similarly y i:n for the second group. Further, the summation of gene expression levels for the ith gene is denoted y i:: .
Three-class Poisson-gamma-beta model for gene expression data
Poisson-Gamma model for gene expression under control condition: First, we assume that the gene expression level for ith gene under control condition is a sample from a Poisson distribution with mean k i , with k i itself having a Gamma distribution with shape parameter j and the rate parameter a, to allow for variations in mean expression across genes. Hence, y ij jk i $ Pois(k i Þ; j ¼ 1; 2; . . . m.
If gene i is an EE gene (x i ¼ 0), then the mean gene expression under control and treatment conditions are the same and the gene expression level under treatment condition follows the same distribution, hence y ij jk i $ Pois(
Beta distribution for modeling fold-change: If gene i is a DR or UR gene, the mean gene expression under treatment group will be different from the control. Let k i be the mean expression level under the control group and k iT be the treatment group counterpart. Let us define d i as the ratio of the smaller relative to the larger of these two means. For DR gene, since
. Given the 'fold change' parameter d i and the mean expression levels in the control group (k i ), the expression levels under treatment condition is assumed to follow a Poisson distribution with parameter k iT . That is, y ij jk i ;
To allow for fold-change variations across genes, we assume d i $ Betaðr; qÞ.
For EE gene, given k i , the gene expression under both experimental conditions are independent realizations from Poisðk i Þ distribution. Hence, the conditional joint density can be written as,
For DR and UR genes, given k i and d i the gene expression across the two experimental conditions are not independent realizations from the same distribution. However, within each condition, they are independent realizations from the same distribution. Because of this, the conditional joint density of gene expression for a DR gene can be written as,
Similarly, for a UR gene, the conditional joint density of gene expression can be written as
The marginal joint density under each DE state can then be calculated by integrating over k i and d i giving
where H ¼ ðj; a; r; qÞ are the parameters of the Gamma and Beta distributions. Unlike for the case of an EE gene, closed-form formulae for f ðy i j x i ¼ 1; HÞ and f ðy i jx i ¼ À1; HÞ are not available. However, Gaussian quadrature can be used to evaluate the double integral for a given H value.
2.3 Three-state discrete local Markov random field model for joint DE states Empirical evidence shows that gene DE states are not independent among genes in the same pathway. Wei and Li (2007) introduced a two-state MRF model to capture this dependency by placing a prior distribution on the DE of a gene. More precisely, the model assumes the probability of a gene being differentially expressed will increase if the gene is surrounded by a higher proportion of neighboring genes that are also differentially expressed. Conversely, if the gene is surrounded by a higher proportion of neighboring genes that are equally expressed, then the probability of that gene being differentially expressed will decrease.
The two-state formulation, however, does not distinguish between up-regulated and down-regulated genes. Instead, all differentially expressed genes are placed into one category, regardless of their direction of change. This opened a possibility not only for the presence of a sizeable up-regulated genes in a pathway where the vast majority are down-regulated (and vice versa) but also the fact that the presence of up-regulated genes in the neighborhood full of down-regulated genes will be encouraged. These properties of the two-state are not supported by the vast majority of experimental data. For example, Grü tzmann et al. (2005), Hong et al. (2014) and Wang et al. (2012) demonstrated the direction of changes among genes in the same pathway is quite consistent.
To tackle this issue, we decided to introduce a three-state MRF model for capturing the dependence among genes in the same pathway. Our MRF model differentiates down-regulated and upregulated and in particular, it ensures that the presence of upregulated genes in the neighborhood full of down-regulated genes and vice versa will not be encouraged.
The proposed discrete local MRF model for joint DE states is a model to incorporate the dependency in DE states using MRF with parameter U ¼ ðc 1 ; c 2 ; b 1 ; b 2 Þ, which describes the conditional probability of state k ¼ fðÀ1Þ; 1g occurring for gene i relative to EE state, given the states of all other genes as, More concretely, the conditional probabilities for the different states above can be written as follows:
where
To understand the difference between our three-state model and the two-state model, consider the following situation: let us assume that the proportion of DR genes in the neighborhood increases by amount at the expense of the proportion of EE genes, while the proportion of UR genes is fixed. We have
Under the two-state model, the probability that gene i is differentially expressed will increase because the total proportion of DE genes, i.e. u Ã i;new ðÀ1Þ þ u Ã i;new ðþ1Þ has increased by amount. The amount of increase in the probability will be the same, regardless the direction of change in gene i. Now, under the three-state model, after some algebraic manipulations, the new probability of being a DR and UR gene (relative to EE gene) can be written as
Moreover, the new probability of having DR relative to UR state can be written as
Thus, we can see that in a three-state model, provided that b 1 > 0; b 2 > 0, the probability of being a DR and UR genes relative to EE gene increases when the proportion of DR genes in the neighborhood increases. However, unlike in the two-state model, the rate of increase in the probability here is favoring the DR state more than the UR state, especially if b 1 is large, since the ratio of probability of being in DR state relative to the UR state now is larger than previously. A large b 1 estimate also indicates very consistent direction of changes among genes in the neighborhood, hence genes are strongly encouraged to have the same state. Interestingly, when b 1 ¼ 0, then an increasing proportion of DR genes will result in the same rate of increase for the probability of being a DR/UR gene. Thus, b 1 estimates close to zero are indicative of a neighborhood that contains a good mixture of up and down-regulated genes, such as is usually found in experiments involving homeostatic processes. When one component of the process is up regulated, there is a controlling down regulation in response (Saxena et al., 2006) . We estimate the parameters U ¼ ðc 1 ; c 2 ; b 1 ; b 2 Þ of the MRF model using maximum likelihood estimation (MLE) for a local MRF model (Besag, 1986) , where the estimate U, denoted b U, is found by maximizing the conditional likelihood function lðx; UÞ ¼ P p i¼1 P i ðx i jx @i ; UÞ. Here, x @i represents the first order neighborhood information for ith gene.
In this paper, we use the BioGRID database (Stark et al., 2006) to form the neighborhood structure, where we define genes to be first-order neighbors if they are recorded as having direct interaction in the BioGRID database. However, in general, any databases that contain network/interaction information can be used to form the neighborhood structure.
Parameter estimation
We use the following iterative conditional mode (ICM) algorithm to estimate the DE states and the underlying parameter H and W. H ¼ fb j; b a; b r; b qg using method of moments (see below).
Estimating Gamma parameters: j and a We first estimate the Poisson parameter (k i ) for gene expression under control condition using the sample mean
Now, according to properties of Gamma distribution,
Equating these theoretical moments to the sample moments, we can estimate the two Gamma parameters, j and a as,
where k and s 2 k are the sample mean and variance calculated using b k i .
Estimating Beta parameters: r and q Let l C i be the expected value under control condition for gene i and l T i be the counterpart under treatment condition. For a DR gene, the fold-change is defined as
and for a UR gene, the fold-change is defined as
Using the current estimate of DE states b x i , for genes currently estimated to be under a DR ðb x i ¼ À1Þ or UR ðb x i ¼ 1Þ state, we estimate the fold-change using the sample moments
Using properties of the Beta distribution, we have
We equate these theoretical moments of d i with the sample moments and estimate the parameters as 
5. Iterate between steps 2-4 until convergence.
The converged estimated DE states, b x , are then taken to be an estimate for the true DE states. These DE state estimates will then mapped back to the gene interaction network to identify the sub networks and biological pathways, which show differential expressions between the two experimental conditions.
3 Simulation studies
Simulation setup
We use simulated data to compare the performance of our proposed approach relative to other approaches for performing DE analysis using RNA-seq data. The data were generated under three-state PGBMRF model. To simulate the data, we obtained the pathway information of 24 human regulatory pathways from the Reactome pathway database (Croft et al., 2014) and the gene network information from the BioGRID gene interaction database (ChatrAryamontri et al., 2015) . We are only interested in gene-gene interactions and any non gene-gene interactions were excluded. The remaining gene-gene interaction information are represented as an undirected graph where each node represents a particular gene and two nodes are connected by an edge if there is an interaction between those genes. This results in a graph with 1065 nodes (genes) and 17 854 edges. We then created a neighborhood matrix based on this graph.
We simulate the gene expression states using the following procedure: first, we calculate the neighborhood information (i.e. the proportion of neighbors in different DE states) by assuming that all genes in K 1 pathways are up-regulated and all genes in K 2 pathways are downregulated and the rest are in EE states. Using these initial neighborhood information, for gene i we draw five observations from discrete distribution with three possible outcomes, x i 2 À1; 0; 1 with the Pðx i ¼ xÞ given by the probabilities under the MRF model with the following parameters U ¼ ðc À1 ¼ 0:5; c 1 ¼ 0:5; b 1 ¼ b 2 ¼ 5Þ. The true DE state for gene i is then determined as the mode out of the five drawn values. We then repeated this sampling process for all genes. Note that due to the stochastic nature of sampling, not all genes in the same pathway will have the same true DE states. (For our simulation studies, the percentages of genes on the same pathway but with different DE states are given in Supplementary Tables S1 and S2. The percentage of DE genes in each pathway ranges from 5 to 54%).
Given the observed DE states, we generate the gene expression data according to the Poisson-Gamma-Beta model with the following parameters H ¼ ða ¼ 0:5; j ¼ 10; r ¼ 2; q ¼ 2Þ. For each gene, the following steps were used to generate the gene expression data
• Generate Poisson mean under the control condition from k i $ Gammaða; jÞ distribution.
• Given k i , we generate the gene expression data for m replicates under the control condition from Pois(k i ).
• If x i ¼ 0, then we also generate the gene expression data for n replicates under the treatment condition from Pois(k i ).
• If x i ¼ À1, we first generate the fold-change parameter d i from Beta(r; q) distribution, then generate the gene expression data for n replicates under treatment from Pois(k i d i ) distribution.
• If x i ¼ 1, we first generate the fold-change parameter d i from the Beta(r; q) distribution and then generate the gene expression data for n replicates under treatment from Pois(
Simulations were repeated 200 times to assess the sensitivity, specificity and false discovery rates (FDRs) of the proposed PGBMRF model. As a comparison, we also analyzed the data using the following approaches: (1) DESeq (Anders and Huber, 2010) , (2) EBSeq (Leng et al., 2013) , (3) edgeR (Robinson et al., 2010) , (4) NOISeq (Tarazona et al., 2011) and (5) a two-state Poisson-Gamma model (PGMRF). To determine differential-expression status, we used adjusted P-values (Benjamini and Hochberg, 1995) 0.05 for DESeq, edgeR and NOISeq while for EBSeq and our method posterior probabilities at FDR ¼ 5% were used. DESeq, EBSeq and edgeR packages are based on methods that assume a NB distribution to model the count data. It has been reported that DESeq and edgeR are especially suited to studies with small sample sizes that are still common in RNA-Seq experiments. The NOISeq package is developed to identify the DE between two experimental conditions with no parametric assumptions (Soneson and Delorenzi, 2013) . The two-state PGMRF model is essentially the same as Wei and Li's two-state model (Wei and Li, 2007) , except that we replaced the Gamma distribution assumption for microarray data with Poisson distribution assumptions more suitable for RNA-seq data.
Simulation study results
The summarized results over 200 realizations are presented in Table 1 . For all methods, except the PGMRF model, sensitivity is calculated as the proportion of differentially expressed (with either DR or UR state) genes identified as having the same state by the method. Specificity is the proportion of EE genes identified as EE and FDR is the proportion of genes with incorrectly estimated state among the declared DE genes. For all methods except the two-state PGMRF, sensitivity and FDR calculation takes into account the direction of regulation. Hence, a UR (DR) gene declared as DR (UR) will be counted as false discoveries and for sensitivity, only UR (DR) genes declared as UR (DR) contributes towards Note that the way we calculate sensitivity and FDR estimates for PGMRF model can be considered as less strict compared to the other methods. For example, a DR gene identified as UR (and vice versa) will still contribute positively towards increasing sensitivity in the case of PGMRF but not in the case of other methods as only those DR (UR) genes identified as DR (UR) will contribute positively. Similarly, for FDR calculation under PGMRF, a DR gene identified as UR (and vice versa) will not contribute to increase the FDR, while for other methods this gene will increase the FDR as its estimated state is different from the underlying state.
Looking at Table 1 , it is clear that overall specificity is high for all methods even for small sample sizes. The DESeq, EBSeq and edgeR have slightly lower specificity, while NOISeq, PGBMRF and PGMRF show a slight gain in specificity as sample size increases. For the same sample size, PGMRF has the highest sensitivity followed PGBMRF, edgeR, DESeq, NOISeq and EBSeq. Meanwhile, NOISeq shows markedly poorer performance with small sample size. However, as sample size increases, the performance of NOISeq becomes better and while it still has lower sensitivity than PGBMRF, edgeR and DESeq, it compensates this with lower FDR. PGMRF has slightly higher sensitivity than PGBMRF but this is also expected given that the sensitivity calculation for PGMRF model is less strict (see above). Finally, comparing DESeq, EBSeq, edgeR and PGBMRF, we can see that our PGBMRF model has noticeably higher sensitivity at the expense of slightly higher FDR, when sample size is small. With large sample sizes, the PGBMRF becomes more sensitive with lower FDR compared to the other methods, with the exception of NOISeq.
Despite the less strict criterion for calculating FDR for the PGMRF model, its FDR is consistently higher than for the PGBMRF model. The higher FDR is largely caused by a few clusters of genes that show a mixture of up-and down-regulation signals. Our simulation setup assumes large b 1 value which means that clusters of differentially expressed genes will show generally consistent direction of changes, hence clusters of genes with inconsistent direction of changes will be correctly classified as EE genes by the three-state PGBMRF model. However, under the two-state PGMRF model, the direction of change is not taken into account and the mixture of up-and down-regulated signals will be treated as consistent signals and consequentially these genes will be incorrectly classified as DE genes. This highlights the benefit of threestate over the two-state model. On the other hand, when the data comes from experiments where clusters of differentially expressed genes are not expected to have consistent direction of changes, our three-state model will reflect this by estimating the magnitude of b 1 to be very small and thus able to identify the clusters of genes with up-and down-regulated signals as differentially expressed ( Table 2) . As expected, the second simulation setup suits the twostate PGMRF model better and this is indicated by its lower FDR, especially for small sample sizes, when compared to its FDR for simulated data where genes in a pathway show consistent direction of changes (Table 1) .
Application to real dataset
Colorectal cancer data
We applied the proposed three-state PGBMRF model to identify DE genes and pathways involved in colorectal cancer (CRC) using GEO dataset GSE50760 from NCBI database. The data were generated as part of study aimed to identify prognostic indicators, including individual responses to chemotherapy, in CRC patients (Kim et al., 2014) . The RNA-Seq dataset comes from 54 samples (normal colon, primary CRC, and liver metastases) from 18 CRC patients. All patients were treated at the Asian Medical Centre(Seoul, Korea) from May 2011 to February 2012 (AMC cohort).
For our analysis, we selected data from nine normal colon samples and nine primary CRC each from different patients. The RNAseq data for these patients were downloaded in both raw (SRA) and processed (FPKM) formats. The downloaded SRA files were converted to fastq using fastq-dump command from sra-toolkit.2.6.2 (Leinonen et al., 2011) . Using FastQC (http://www.bioinformatics. babraham.ac.uk/projects/fastqc/), the quality of the paired-end reads were inspected and upon inspection, the last 20 nucleotides of all reads were trimmed. The reads were aligned UCSC hg19 reference genome (Fujita et al., 2011) using Bowtie2-2.2.9 version (Langmead and Salzberg, 2012) and finally number of reads that overlap each transcript was counted using HTSeq-0.6.0 (Anders et al., 2015) .
The count data were used as input to DESeq, EBSeq, edgeR and NOISeq packages, whereas the FPKM data were used as input to PGMRF and PGBMRF methods. Differentially expressed genes were then analyzed for enriched Gene Ontology (GO) terms using Cytoscape 3.4.0 (Shannon et al., 2003) with BiNGO enrichment tool (Maere et al., 2005) . Only 6606 genes that can be mapped to at least one pathway in the Reactome pathway database (Croft et al., 2014) were included in our analysis. The neighborhood structure was formed using information from the BioGRID gene interaction database (Chatr-Aryamontri et al., 2015) and neighborhood matrix was constructed using ENA 1.3-0 package in R (Allen and Xiao, 2014) .
In Table 3 , we can see that edgeR, EBSeq and PGMRF have declared more than 25% of genes as DE among total genes. The NOISeq (15%) and PGBMRF (14%) identified relatively same amount of DE genes while the DESeq discovered the lowest amount of DE genes as around 10% from the total genes. Two methods, edgeR and PGBMRF identify more genes not detected by other methods (Fig. 1) . However, edgeR achieves this more sensitive detection by declaring higher proportion of DE genes, thus potentially increasing FDR while PGBMRF does not.
As we do not know the true expression status of these genes, we cannot perform direct comparison to assess the performance of the different methods. Instead, we compared our findings to results in Lascorz et al. (2011) that were based on three recent meta-analyses covering 34 Gene Expression Profiling (GEP) studies on genes differentially expressed in colorectal cancer, published between the years 2001 and 2007. This article also reported the top 10 Gene Ontology-Biological Process (GO-BP) terms found to be enriched among genes found to be differentially expressed by the metaanalyses. We performed GO tests using the list of differentially expressed genes identified under each method. Table 4 shows that our proposed three-state PGBMRF model was able to identify 4 out of the 10 important GO-BP terms among top 20 most significantly enriched terms. On the other hand, the DESeq, EBSeq, edgeR and NOISeq identified 3 out of 10 while the two-state PGMRF was only able to identify 2 out of 10 important GO-BP terms are among their top 20 significant GO-BP terms. It is noticeable that our PGBMRF was able to identify all 10 important GO-BP terms found to be enriched in colorectal cancer (Lascorz et al., 2011) .
This real data analysis also shows that utilizing prior network information can boost power to identify important genes and pathways as demonstrated by our proposed method, using only nine replicates in each group, we could identify about half of the important GO-BP terms within our top 20 enriched GO-BP terms, which were previously identified in meta-analyses involving 34 different studies.
Hepatocellular carcinoma data
For the second real data application, we downloaded RNA-Seq data from hepatocellular carcinoma (HCC) study (Liu et al., 2016) . The data were obtained by Shanghai Institute of biological sciences, China from 50 HCC patients as paired liver normal tissue and tumor tissue samples. For our analysis, we selected 15 normal samples and 15 tumor samples from different HCC patients. The RNASeq data for this study is available in GEO (GSE77314) as both raw and processed (FPKM) formats.
We used the same procedure to obtain count data from raw data files, which is explained in Section 4.1. The selected data samples were analyzed using DESeq, EBSeq, edgeR, NOISeq, PGMRF and PGBMRF models. Out of 26 364 genes, only 5831 genes that mapped to at least one pathway in Reactome pathway database (Croft et al., 2014) were included in the analysis. The neighborhood structure was incorporated using the BioGRID gene interaction database (ChatrAryamontri et al., 2015) and neighborhood matrix was constructed using ENA 1.3-0 package in R (Allen and Xiao, 2014 ). Differentially expressed genes were then analyzed to find enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways using Functional Annotation Tool DAVID Bioinformatics Resources 6.8 (Huang et al., 2009a, b) In Table 5 , we can see that PGMRF and PGBMRF identified about 51% of genes as DE among total genes. The edgeR (37%) and EBSeq (32%) identified relatively same amount of DE genes while the NOISeq (17%) and DESeq (11%) discovered a lower number of DE genes. There was also not much overlap in the DE genes among the methods with about 40% of DE genes discovered by PGBMRF model were not replicated by DESeq, EBSeq or NOISeq, which were also performed well in this analysis (Fig. 2) .
We compared our findings with the results from transcriptome meta-analysis on hepatocellular carcinoma (HCC) microarray data Likhitrattanapisal et al. (2016) . In that study, the authors reported top 10 differentially expressed KEGG pathways in HCC. Table 6 shows that PGBMRF model identified 5 out of 10 important KEGG pathways among the top 10 pathways with the smallest P-values. The DESeq, EBSeq, NOISeq and PGMRF identified 4 out of 10 important KEGG pathways while edgeR was able to identify only 3 out of 10 important KEGG pathways among most 10 significant pathways.
Discussion
We have proposed a three-state MRF method that uses known biological pathways and interaction to improve sensitivity and specificity and to reduce FDRs when detecting differentially expressed genes from RNA-seq data. The method requires normalized count data (e.g. in FPKM or RPKM format) as its input and it is implemented in an R package pathDESeq available from Github. Simulation studies demonstrate that our proposed method outperforms the previously published two-state MRF model (Wei and Li, 2007) for various sample sizes and it has better sensitivity than DESeq (Anders and Huber, 2010) , EBSeq (Leng et al., 2013) , edgeR (Robinson et al., 2010) and NOISeq (Tarazona et al., 2011) . This highlights the need to treat up-and down-regulated as separate categories when performing differential-expression analysis and the potential benefit of utilizing prior information in the form of known biological network for small RNA-seq study.
The results from analyzing a small colorectal cancer RNA-Seq dataset identified several important GO terms related to colorectal cancer (Lascorz et al., 2011) and the result from analyzing hepatocellular carcinoma (Liu et al., 2016) dataset identified several important KEGG pathways related to hepatocellular carcinoma. These findings clearly highlight the power of our method relative to methods that do not utilize prior biological network information. As the cost of sequencing becomes cheaper, we expect that the sample size in RNA-seq study will increase. However, the increase in the overall sample size may not always coincide with the increase in the overall quality of the data. As long as the signal-to-noise ratio is low, utilizing methods that make use of prior biological information such as ours is still relevant and will result in improved detection of the differentially expressed genes.
